ABATACEPT

Clinical trials for ABATACEPT explained in plain language.

Never miss a new study

Get alerted when new ABATACEPT trials appear

Sign up with your email to follow new studies for ABATACEPT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New shot may shield transplant patients from deadly immune attack

Prevention Completed

This study tested a drug called abatacept, given as a shot under the skin, to prevent a serious complication called graft-versus-host disease (GVHD) in 29 adults with blood cancers. Participants received a stem cell transplant from a half-matched donor. The goal was to see if aba…

Matched conditions: ABATACEPT

Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention

Last updated Jun 27, 2026 13:06 UTC

ABATACEPT

Get alerted when new ABATACEPT trials appear

New shot may shield transplant patients from deadly immune attack